Position in ABVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,801,156
+$7,019,556 QoQ
Shares Held
66,045
+312.8% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#92
of 302 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Derivatives in ABVX
reported options exposure · as of Jun 30, 2026CallValue
$3,997,800
CallShares
30,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quinn Opportunity Partners LLC holds $47,802,755 across 24 Biotechnology names. ABVX ranks #3 (18.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BNTX |
BioNTech SE
|
153,832 | $14,314,067 | |
| 2 | NKTR |
Nektar Therapeutics
|
153,076 | $10,686,235 | |
| 3 | ABVX |
Abivax S.A.
This page
|
66,045 | $8,801,156 | |
| 4 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
265,070 | $1,654,036 | |
| 5 | XNCR |
Xencor Inc
|
90,000 | $1,449,000 | |
| 6 | SPRB |
Spruce Biosciences, Inc.
|
26,810 | $1,447,740 | |
| 7 | SPRY |
ARS Pharmaceuticals, Inc.
|
175,000 | $1,401,750 | |
| 8 | ABUS |
Arbutus Biopharma Corp
|
255,214 | $1,225,027 |
All Filings in ABVX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,997,800 | 30,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $8,801,156 | 66,045 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,781,600 | 16,000 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $2,631,900 | 31,000 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||